A riboflavin auxotroph of Actinobacillus pleuropneumoniae is attenuated in swine

Infection and Immunity

Volumn 64, Issue 11, 1996, Pages 4659-4664

  Fuller, Troy E ^a   Thacker, Brad J ^b   Mulks, Martha H ^a  

^a Michigan State University ^*  (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; DNA; KANAMYCIN; RIBOFLAVIN; RIBOFLAVIN SYNTHASE;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL DISEASE; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; AUXOTROPHIC MUTANT; BACTERIAL GROWTH; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; BACTERIUM MUTANT; DELETION MUTANT; ENZYME ACTIVITY; LUNG INFECTION; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 0029862455     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.11.4659-4664.1996     Document Type: Article

References (41)

1. Ahmed, Z. U., M. R. Sarker, and D. A. Sack. 1990. Protection of adult rabbits and monkeys from lethal shigellosis by oral immunization with a thymine-requiring and temperature-sensitive mutant of Shigella flexneri Y. Vaccine 8:153-158.
2. Bacher, A. 1991. Biosynthesis of flavins, p. 215-259. In F. Muller (ed.), Chemistry and biochemistry of flavins, vol. 1. Chemical Rubber Company, Boca Raton, Fla.
3. Collins, L. V., S. Attridge, and J. Hackett. 1991. Mutations at rfc or pmi attenuate Salmonella typhimurium virulence for mice. Infect. Immun. 59: 1079-1085.
4. Fenwick, B., and S. Henry. 1994. Porcine pleuropneumonia. J. Am. Vet. Med. Assoc. 204:1334-1340.
5. Fuller, T. E., and M. H. Mulks. 1995. Characterization of Actinobacillus pleuropneumoniae riboflavin biosynthesis genes. J. Bacteriol. 177:7265-7270.
6. Hoiseth, S. K., and B. A. D. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature (London) 291:238-239.
7. Homchampa, P., R. A. Strugnell, and B. Adler. 1992. Molecular analysis of the aroA gene of Pasteurella multocida and vaccine potential of a constructed aroA mutant. Mol. Microbiol. 6:3585-3593.
8. Homchampa, P., R. A. Strugnell, and B. Adler. 1994. Construction and vaccine potential of an aroA mutant of Pasteurella haemolytica. Vet. Microbiol. 42:35-44.
9. Hunneman, W. A. 1986, Incidence, economic effects, and control of Haemophilus pleuropneumoniae infections in pigs. Vet. Q. 8:83-87.
10. Inzana, T. J., J. Todd, and H. P. Veit. 1993. Safety, stability and efficacy of nonencapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines. Infect. Immun, 61:1682-1686.
11. Jolie, R. A. V., M. H. Mulks, and B. J. Thacker. 1994. Antigenic differences within Actinobacillus pleuropneumoniae serotype 1. Vet. Microbiol. 38:329-349.
12. Jolie, R. A. V., M. H. Mulks, and B. J. Thacker. 1995. Cross-protection experiments in pigs vaccinated with Actinobacillus pleuropneumoniae subtypes 1A and 1B. Vet. Microbiol. 45:383-391.
13. Karnell, A., P. D. Cam, N. Verma, and A. A. Lindberg. 1493. AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys. Vaccine 8:830-836.
14. Kelly, S. M., B. A. Bosecker, and R. Curtiss III. 1992. Characterization and protective properties of attenuated mutants of Salmonella choleraesuis. Infect. Immun. 60:4881-4890.
15. Kimura, A., and E. J. Hansen. 1986. Antigenic and phenotypic variations of Haemophilus influenzae type B lipopolysaccharide and their relationship to virulence. Infect. Immun. 51:69-79.
16. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
17. Lindberg, A. A., A. Karnell, B. A. D. Stocker, S. Katakura, H. Sweiha, and F. P. Reinholt. 1988. Development of an auxotrophic oral live Shigella flexneri vaccine. Vaccine 6:146-150.
18. Miller, V. L., and J. J. Mekalanos. 1988. A novel suicide vector and its use in construction of insertion mutants: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J. Bacteriol. 170:2575-2583.
19. Mulks, M. H., and J. M. Buysse. 1995. A targeted mutagenesis system for Actinobacillus pleuropneumoniae. Gene 165:61-66.
20. Nicolet, J. 1992. Actinobacillus pleuropneumoniae, p. 401-408. In A. D. Leman et al. (ed.), Diseases of swine, 7th ed. Iowa State University Press, Ames.
21. Nielsen, R. 1974. Serological and immunulogical studies of pleuropneumonia of swine caused by Haemophilia parahaemolyticus. Acta Vet. Scand. 15:80-89.
22. Nielsen, R. 1976. Pleuropneumonia of swine caused by Haemophilus pleuropneumonia. Studies on the protection obtained by vaccination. Nord. Vet. Med. 28:337-338.
23. Nielsen, R. 1979. Haemophilus parahaemolyticus serotypes: pathogenicity and cross immunity. Nord. Vet. Med. 31:407-413.
24. Nielsen, R. 1984. Haemophilus pleuropneumoniae serotypes-cross protection experiments. Nord. Vet. Med. 36:221-234.
25. Nnalue, N. A., and B. A. D. Stocker. 1987. Tests of the virulence and live-vaccine efficacy of auxotrophic and galE derivatives of Salmonella choleraesuis. Infect. Immun. 55:955-962.
26. O'Callaghan, D., D. Maskell, F. Y. Liew, C. S. F. Easmon, and G. Dougan. 1988. Characterization of aromatic- and purine-dependent Salmonella typhimurium: attenuation, persistence, and ability to induce protective immunity in BALB/c mice. Infect. Immun. 56:419-423.
27. Paltineanu, D., R. Pambucol, E. Tirziu, and I. Scobercea. 1992. Swine infectious pleuropneumonia: aerosol vaccination with a live attenuated vaccine. Proc. Int. Pig Vet. Soc. 12:214.
28. Perry, M. B., E. Altman, J.-R. Brisson, L. M. Beynon, and J. C. Richards. 1990. Structural characteristics of the antigenic capsular polysaccharides and lipopolysaccharides involved in the serological classification of Actinobacillus pleuropneumonia strains. Serodiagn. Immunother. Infect. Dis. 4:299-308.
29. Rosendal, S., D. S. Carpenter, W. R. Mitchell, and M. R. Wilson. 1981. Vaccination against pleuropneumonia in pigs caused by Haemophilus pleuropneumoniac. Can. Vet. J. 22:34-35.
30. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Press, Cold Spring Harbor, N.Y.
31. Schott, K., J. Kellerman, F. Lottspeich, and A. Bacher. 1990. Riboflavin synthases of Bacillus subtilis: purification and amino acid sequence of the α-subunit. J. Biol. Chem. 265:4204-4209.
32. Sebunya, T. N. K., and J. R. Saunders. 1983. Haemophilia pleuropneumoniae infection in swine: a review. J. Am. Vet. Med. Assoc. 182:1331-1337.
33. Sigwart, D. F., B. A. D. Stocker, and J. D. Clements. 1989. Effect of a purA mutation on the efficacy of Salmonella live vaccine vectors. Infect. Immun. 57:1858-1861.
34. Silhavy, T. J. 1984. DNA extraction from bacterial cells, p. 137-139. In T. J. Silhavy et al. (ed.), Experiments with gene fusions. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
35. Simon, R., U. Priefer, and A. Puhler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram negative bacteria. Bio/Technology 1:784-791.
36. Tacket, C. O., D. M. Hone, R. Curtiss III, S. M. Kelly, G. Losonsky, L. Guers, A. M. Harris, R. Edelman, and M. M. Levine. 1992. Comparison of the safety and immunogenicity of ΔaroC ΔaroD and Δcya Δcrp Salmonella typhi strains in adult volunteers. Infect. Immun. 60:536-541.
37. Thacker, B. J., and M. H. Mulks. 1988. Evaluation of commercial Haemophilus pleuropneumoniae vaccines. Proc. Int. Pig Vet. Soc. 10:87.
38. Utrera, V., C. Pijoan, and T. Molitor. 1992. Evaluation of the immunity induced in pigs after infection with a low virulence strain of A. pleuropneumoniae serotype 1. Proc. Int. Pig Vet. Soc. 12:213.
39. Vaughan, L. M., P. R. Smith, and T. J. Foster. 1993. An aromatic-dependent mutant of the fish pathogen Aeromonas salmonicida is attenuated in fish and is effective as a live vaccine against the salmonid disease furunculosis. Infect. Immun. 61:2172-2181.
40. Vieira, J., and J. Messing. 1982. The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene 19:259-268.
41. West, S. E. H., M. J. M. Romero, L. B. Regassa, N. A. Zielinski, and R. A. Welch. 1995. Construction of Actinobacillus pleuropneumoniae-Escherichia coli shuttle vectors: expression of antibiotic resistance genes. Gene 160:81-86.